Skip to main content
ABIVAX Société Anonyme (ABVX)
NASDAQ: ABVX · Real-Time Price · USD
7.02
-0.40 (-5.39%)
At close: Jun 12, 2025, 4:00 PM
7.02
0.00 (0.00%)
After-hours: Jun 12, 2025, 4:00 PM EDT

ABIVAX Société Anonyme Revenue

ABIVAX Société Anonyme had revenue of 4.01M EUR in the half year ending December 31, 2024, with 78.20% growth. This brings the company's revenue in the last twelve months to 10.59M, up 128.98% year-over-year. In the year 2024, ABIVAX Société Anonyme had annual revenue of 10.79M with 135.94% growth.

Revenue (ttm)
10.59M EUR
Revenue Growth
+128.98%
P/S Ratio
40.10
Revenue / Employee
153,449 EUR
Employees
69
Market Cap
458.89M USD

Revenue Chart

* This company reports financials in EUR.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202410.79M6.22M135.94%
Dec 31, 20234.57M69.00K1.53%
Dec 31, 20224.51M302.00K7.19%
Dec 31, 20214.20M4.19M29,921.43%
Dec 31, 202014.00K21.00K-300.00%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 410.06B
Johnson & Johnson 89.33B
Merck & Co. 63.92B
AbbVie 57.37B
AstraZeneca 54.98B
Novartis AG 53.22B
Eli Lilly and Company 49.00B
Novo Nordisk 43.92B
Revenue Rankings

ABVX News

More News